Mark Fletcher is President at GENEREX BIOTECHNOLOGY CORP (GNBT). They have made 6 open-market trades across 1 company since 2008, most recently 2016-02-16.
CIK 0001229529
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
5 open-market purchases totalling $28K since 2008, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| GNBT | 15,821,836 | — |
Shares reported on the most recent Form 4, priced at the 2016-02-16 close. 1 holding could not be priced and is excluded from the total.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| GNBT | BUY | 2011-04-06 | 2011-04-07 | $0.24 | $5K | N/A | N/A | N/A |
| GNBT | BUY | 2010-01-04 | 2010-01-04 | $0.52 | $5K | N/A | N/A | N/A |
| GNBT | BUY | 2009-11-13 | 2009-11-16 | $0.49 | $5K | N/A | N/A | N/A |
| GNBT | BUY | 2009-01-12 | 2009-01-12 | $0.32 | $4K | N/A | N/A | N/A |
| GNBT | BUY | 2008-10-31 | 2008-11-03 | $0.38 | $9K | N/A | N/A | N/A |
| GNBT | SELL | 2008-04-18 | 2008-04-21 | $1.15 | $263K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.